Join to View Full Profile
277 George StNew Brunswick, NJ 08901
Phone+1 732-235-6700
Dr. Marcella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Bridgeport Hospital/Yale UniversityResidency, Pediatrics, 1984 - 1987
Albany Medical CenterInternship, Internal Medicine, 1983 - 1984
New York University School of MedicineClass of 1983
Certifications & Licensure
NJ State Medical License 1995 - 2027
PA State Medical License 1987 - 1996
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer Start of enrollment: 2003 Jun 01
Publications & Presentations
PubMed
- Assessment of the Haemostatic Potential of Platelets Readied for Transfusion.Unwana Emagha, Khawla Yousif, Michelle Duff, Edwina Geraghty, Janice O'Shaughnessy
TH Open. 2025-01-01 - 7 citationsEffectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study.Cornelius J Clancy, Oliver A Cornely, Stephen W Marcella, Sean T Nguyen, Laurence Gozalo
Infection and Drug Resistance. 2024-01-01 - 3 citationsSystematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Proce...Michelle E Orme, Roy Bentley, Stephen Marcella, Markus Peck-Radosavljevic, Rodolphe Perard
Advances in Therapy. 2022-09-01
Journal Articles
- Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab with Antibacterial Drug Treatment for Clostridium Difficile InfectionStephen Marcella, Yoav Golan, Clinical Infectious Diseases
Press Mentions
Novel Siderophore Cephalosporin Nets Promising Results in Tough-to-Treat CRABOctober 23rd, 2022- Shionogi to Present in Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (Cefiderocol) Against Gram-Negative PathogensSeptember 29th, 2021
Significant Costs Linked to Hospital-Acquired C. DifficileJuly 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
